Drugs / synbiotics
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00298337 | Oct 1999 → Dec 2007 | asthma, atopic conjunctivitis, atopic eczema, food allergy +1 | University of Helsinki | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06169566 | Jan 2024 → Dec 2025 | polycystic ovary syndrome | Maharaj Nakorn Chiang Mai Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | synbiotics | “The randomly selected group of 102 infants belonged to a randomized, double-blind placebo-controlled trial where 1223 infants in high risk for allergy received, from birth to 6...” PMID 22093109 ↗ Nov 20111“Dietary Supplement: synbiotics” NCT06169566 ↗ |
| Modality | Other / unclassified | “Live probiotic bacteria and dietary prebiotic oligosaccharides (together termed synbiotics)” PMID 18595980 ↗ Jul 2008 |
| Route | Oral | “feeding synbiotics to newborn infants” PMID 18595980 ↗ Jul 2008 |